Oncolytics Biotech (ONCY) Tops Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Abitibi Metals names new CFO, halts drilling on Quebec fire order
• LG Energy 2q Oper Profit 113.3b Won, Est. 210.66b Won - Bloomberg